Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia-Reference-Cited by-同舟云学术

Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia

Published:2000-06 Issue:2 Volume:150 Page:421-428
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Raal Frederick J.,Pappu Anuradha S.,Illingworth D.Roger,Pilcher Gillian J.,Marais A.David,Firth Jean C.,Kotze Maritha J.,Heinonen Therese M.,Black Donald M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Familial hypercholesterolaemia;Goldstein,1992

2. Cardiovascular complications of homozygous familial hypercholesterolaemia;Allen;Br. Heart J.,1980

3. Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia;Raal;Atherosclerosis,1997

4. Decreased production of low density lipoprotein by atorvastatin in homozygous familial hypercholesterolaemia;Marais;J. Lipid Res.,1997

5. Metabolism of mevalonate in rats and humans;Kopito;J. Lipid Res.,1982

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale for Increasing Doses of Statins in Everyday Clinical Practice;Kardiologiia;2024-08-31

2. Unveiling Familial Hypercholesterolemia—Review, Cardiovascular Complications, Lipid-Lowering Treatment and Its Efficacy;International Journal of Molecular Sciences;2024-01-29

3. Familial hypercholesterolemia and its manifestations: Practical considerations for general practitioners;Kardiologia Polska;2023-11-30

4. Familial Hypercholesterolemia: A Literature Review of the Pathophysiology and Current and Novel Treatments;Cureus;2023-11-20

5. Modelling the potential long-term survival benefit of evinacumab treatment vs. standard of care in patients with homozygous familial hypercholesterolaemia;European Journal of Preventive Cardiology;2023-06-14